Vaccine News and Research

Latest Vaccine News and Research

Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

In a paper in the journal Nature, Los Alamos National Laboratory scientists Bette Korber, Hyejin Yoon, Will Fischer and James Theiler, among nearly 130 authors from institutions around the world, describe their groundbreaking collaborative work, "Defining the risk of SARS-CoV-2 variants on immune protection."

1 Apr 2022

Study investigates messenger ribonucleic acid-based SARS-CoV-2 vaccine efficacy against SARS-CoV-2 Omicron in Denmark

A new study assessed the efficacy of two SARS-CoV-2 vaccines against Omicron infections and disease-related hospitalization in the Denmark population.

1 Apr 2022

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Researchers developed a novel high-throughput method to obtain monoclonal antibodies from COVID-19 individuals infected with SARS-CoV-2 ancestral strain Wuhan-Hu-1 and the Beta or Gamma variants.

1 Apr 2022

Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

The work investigated why the children experienced milder COVID-19 illness even after a strong immune response.

1 Apr 2022

Scientists evaluate the SARS-CoV-2 neutralizing ability of two-dose BNT162b2 vaccination

A new study analyzed the SARS-CoV-2 neutralizing capacity of sera samples from two-dose BNT162b2 vaccinated Japanese subjects.

1 Apr 2022

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

Connie Houtz didn't think covid would be that bad. She'd seen many people in this rural hamlet in central Pennsylvania get infected yet recover within a few days. She did not get vaccinated because she worried about how a new vaccine, developed in record time, might affect her heart condition.

1 Apr 2022

Study reveals how zinc supports immunity, suggests ways it could be used to improve health

Zinc's immune-boosting properties are well-established, but scientists haven't known exactly how it works.

1 Apr 2022

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Faculty from the Departments of Microbiology, Medicine Genetics and Genomic Sciences, and Pathology and Molecular Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai play key roles in a National Institutes of Health (NIH) program set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program, called SARS-CoV-2 Assessment of Viral Evolution (SAVE) and described in a paper published March 31 in Nature, assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vaccine-induced immunity.

31 Mar 2022

Potential new approach could make Japanese encephalitis vaccine more affordable

A potential new approach to administering an existing Japanese encephalitis (JE) vaccine could make it more affordable and increase dose numbers in Australia.

31 Mar 2022

The longest duration of SARS-CoV-2 positivity after initial diagnosis

An immunocompetent individual with prolonged SARS-CoV-2 shedding 221 days after their initial COVID-19 diagnosis.

31 Mar 2022

Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

Data continue to show the importance of vaccination and booster doses to protect individuals both from infection and severe outcomes of COVID-19.

31 Mar 2022

KHN’s ‘What the Health?’: Funding for the next pandemic

President Joe Biden released his budget proposal for 2023 this week, and it calls for a nearly 27% increase in funding for the Department of Health and Human Services.

31 Mar 2022

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States.

31 Mar 2022

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

A new study investigated the impact of pre-existing SARS-CoV-2 infection-induced immunity on vaccine-induced immunity.

31 Mar 2022

Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

In a new study, researchers determined the risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated individuals.

31 Mar 2022

Mosaic-8 RBD-nanoparticles show promise as a vaccine candidate for SARS-CoV-2 and potential sarbecoviruses spillovers

Researchers designed nanoparticles representing RBDs of the S protein of animal sarbecoviruses and SARS-CoV-2 to evaluate their potential as a pan-sarbecovirus vaccine candidate.

31 Mar 2022

Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

Researchers evaluated the protection conferred by booster doses of the preclinical version of the Moderna mRNA-1273 vaccine and a SARS-CoV-2 Omicron variant-matched vaccine against Omicron infections in mice.

31 Mar 2022

‘The danger is still there’ ― As omicron lurks, Native Americans are wary of boosters

When covid-19 vaccines first became available, Native Americans acted swiftly and with determination to get their shots — as though they had everything to lose.

31 Mar 2022

Booster doses provide strong protection against hospitalization and death from COVID-19

Booster doses of mRNA vaccines provided strong protection against hospitalization and death from COVID-19 in Qatar, though breakthrough SARS-CoV-2 infections were greater for the omicron variant compared with the delta variant, according to a study by investigators at Weill Cornell Medicine—Qatar.

30 Mar 2022

Inconsistency in disease severity across SARS-CoV-2 variants

Researchers determine how the severity of successively dominant SARS-CoV-2 variants has changed since the beginning of the pandemic.

30 Mar 2022

Vaccine News and Research

Latest Vaccine News and Research

Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

Study investigates messenger ribonucleic acid-based SARS-CoV-2 vaccine efficacy against SARS-CoV-2 Omicron in Denmark

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

Scientists evaluate the SARS-CoV-2 neutralizing ability of two-dose BNT162b2 vaccination

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

Study reveals how zinc supports immunity, suggests ways it could be used to improve health

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Potential new approach could make Japanese encephalitis vaccine more affordable

The longest duration of SARS-CoV-2 positivity after initial diagnosis

Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

KHN’s ‘What the Health?’: Funding for the next pandemic

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

Mosaic-8 RBD-nanoparticles show promise as a vaccine candidate for SARS-CoV-2 and potential sarbecoviruses spillovers

Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

‘The danger is still there’ ― As omicron lurks, Native Americans are wary of boosters

Booster doses provide strong protection against hospitalization and death from COVID-19

Inconsistency in disease severity across SARS-CoV-2 variants

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in